Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 177 shares at $25.00 ($4K) on 2019-06-19, disclosed to the SEC on 2019-06-21.
Scheduled sale ($4k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |